Article List
-
Meet Our Editorial Board Member
Author(s): Nigel J. Waters
Pages: 77-78 (2)
Free -
Potential of Mirabegron and its Extended-release Formulations for the Treatment of Overactive Bladder Syndrome
Author(s): Pankaj Mandpe, Bala Prabhakar and Pravin Shende*
Pages: 79-88 (10)
-
Clinical Pharmacokinetics of Propranolol Hydrochloride: A Review
Author(s): Muhammad Nasir Kalam , Muhammad Fawad Rasool , Asim Ur Rehman and Naveed Ahmed *
Pages: 89-105 (17)
-
Advances and Application of a Novel Oral Anticoagulant in Specific Populations: Dabigatran Etexilate
Author(s): Delai Xu, Cujin Su and Jie Pan*
Pages: 106-111 (6)
-
Has the Time Come to Employ Population and Individual Bioequivalence for the Evaluation of Generics?
Author(s): Francis Micheal*, Mohanlal Sayana, Rajendra Prasad and Balamurali Musuvathi Motilal
Pages: 112-125 (14)
-
Clinical Impact of Co-medication of Levetiracetam and Clobazam with Proton Pump Inhibitors: A Drug Interaction Study
Author(s): Bhuvanachandra Pasupuleti, Vamshikrishna Gone*, Ravali Baddam, Raj Kumar Venisetty and Om Prakash Prasad
Pages: 126-131 (6)
-
Pharmacokinetics/Pharmacodynamics (PK/PD) of Ciprofloxacin in the Complicated Urinary Tract Infection (cUTI) Model in Diabetic Mice
Author(s): Mahesh Kumar Reniguntla, Randhir Yedle, Ramesh Puttaswamy, Pradeep Puttarangappa , Somashekharayya Hiremath, Avinash Pawar, Mahesh Nanjundappa and Ramesh Jayaraman *
Pages: 132-139 (8)
-
AOX1 and XDH Enzymes Genotyping and its Effect on Clinical Response to Azathioprine in Inflammatory Bowel Disease Patients Among Jordanian Population
Author(s): Sereen Mahasneh, Ahmad Sharab, Mohammad Al Shhab, Mohammad Rashid and Malek Zihlif*
Pages: 140-144 (5)
-
Further Considerations Towards an Effective and Efficient Oncology Drug Discovery DMPK Strategy
Author(s): Beth Williamson , Nicola Colclough, Adrian John Fretland, Barry Christopher Jones, Rhys Dafydd Owen Jones and Dermot Francis McGinnity *
Pages: 145-162 (18)